Lawrence Steinman
Affiliations: | Stanford University, Palo Alto, CA |
Area:
Neurology and Neurological SciencesGoogle:
"Lawrence Steinman"Mean distance: 35622
Children
Sign in to add trainee| Jason J. DeVoss | grad student | 2003 | Stanford |
| Eun M. Hur | grad student | 2006 | Stanford |
| May Htwe Han | post-doc | 2005-2009 | Stanford Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hartung HP, Cree BAC, Barnett M, et al. (2023) Bioavailable central nervous system disease-modifying therapies for multiple sclerosis. Frontiers in Immunology. 14: 1290666 |
| Hashemi E, Srivastava IN, Aguirre A, et al. (2023) A novel mouse model of cerebral adrenoleukodystrophy highlights NLRP3 activity in lesion pathogenesis. Biorxiv : the Preprint Server For Biology |
| Mader MM, Napole A, Wu D, et al. (2023) Augmentation of a neuroprotective myeloid state by hematopoietic cell transplantation. Biorxiv : the Preprint Server For Biology |
| Chen BY, Salas JR, Trias AO, et al. (2022) Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis. Immunology |
| Kuerten S, Lanz TV, Lingampalli N, et al. (2020) Autoantibodies against central nervous system antigens in a subset of B cell-dominant multiple sclerosis patients. Proceedings of the National Academy of Sciences of the United States of America |
| Steinman L. (2020) A sugar-coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD-19: An Editorial Highlight for "Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer"on https://doi.org/10.1111/jnc.15021. Journal of Neurochemistry |
| Frohman EM, Villemarette-Pittman NR, Melamed E, et al. (2020) Part I. SARS-CoV-2 triggered 'PANIC' attack in severe COVID-19. Journal of the Neurological Sciences. 116936 |
| Villoslada P, Steinman L. (2020) New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis. Expert Opinion On Investigational Drugs. 1-17 |
| Bar-Or A, Pender MP, Khanna R, et al. (2019) Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies. Trends in Molecular Medicine |
| Steinman L, Ho PP, Robinson WH, et al. (2019) Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity. Current Opinion in Immunology. 61: 46-53 |